Management of intracoronary thrombosis complicating percutaneous transluminal coronary angioplasty

Clinical Cardiology

Volumn 19, Issue 7, 1996, Pages 536-542

  Boston, David R ^a,c   Malouf, Assaad ^b   Barry, William H ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b SAINT GEORGE HOSPITAL UNIVERSITY MEDICAL CENTER   (Lebanon)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

acute occlusion; intracoronary thrombus; percutaneous transluminal coronary angioplasty; urokinase

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HEPARIN; HIRULOG; IONIC CONTRAST MEDIUM; LEPIRUDIN; STREPTOKINASE; THROMBIN INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY THROMBOSIS; FIBRINOLYTIC THERAPY; HEPARINIZATION; HUMAN; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; LASER ANGIOPLASTY; REVIEW; STENT; THROMBECTOMY; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0029836191     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960190704     Document Type: Review

References (62)

1. Detre KM, Holmes DR, Holubkov R, Cowley MJ, Bourassa MG, Faxon DP, Dorros GR, Bentivoglio LG, Kent KM, Myler RK (1985-86 NHLBI PTCA registry): Incidence and consequences of periprocedural occlusion. Circulation 82, 739-750 (1990)
2. Ferguson JJ, Barasch E, Wilson JM, Strony J, Wolfe MW, Schweiger MJ, Leya F, Bonan R, Isner JM, Roubin GS, Cannon AD, Cleman M, Cabin HS, Adelman B, Bittl JA, and the Heparin Registry Investigators: The relation of clinical outcome to dissection and thrombus formation during coronary angioplasty. J Invas Cardiol 7, 2-10 (1995)
3. Roubin GS, Cannon AD, Agrawal SK, Macander PJ, Dean LS, Baxley WA, Breland J: Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 85, 916-927 (1992)
4. Haude M, Erbel R, Straub U, Dietz U, Schatz R, Meyer J: Results of intracoronary stents for the management of coronary dissection after balloon angioplasty. Am J Cardiol 67, 691-696 (1991)
5. de Feyter PJ, de Jaegere PPT, Serruys PW: Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty. Am Heart J 127, 643-651 (1994)
6. Tierstein PS, Schatz RA, DeNardo SJ, Jensen EE, Johnson AD: Angioscopic versus angiographic detection of thrombus during coronary interventional procedures. Am J Cardiol 75, 1083-1087 (1995)
7. Potkin BN, Keren G, Mintz GS, Douek PC, Pichard AD, Satler LF, Kent KM, Leon MB: Arterial responses to balloon coronary angioplasty: An intravascular ultrasound study. J Am Coll Cardiol 20, 942-951 (1992)
8. Steele PM, Chesebro JH, Stanson AW, Holmes DR Jr, Dewanjee MK, Badimon L, Fuster V: Balloon angioplasty: Natural history of the pathophysiological response to injury in a pig model. Circ Res 57, 105-112 (1985)
9. Neumann F, Ott I, Gawaz M, Puchner G, Schomig A: Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. J Am Coll Cardiol 1996;27: 819-824
10. Mabin TA, Holmes DR Jr, Smith HC, Vlietstra RE, Bove AA, Reeder GS, Chesebro JH, Bresnahan JF, Orszulak TA: Intracoronary thrombus: Role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 5, 198-202 (1985)
11. Rehr R, Disciascio G, Vetrovec G, Cowley M: Angiographic morphology of coronary artery stenoses in prolonged rest angina: Evidence of intracoronary thrombosis. J Am Coll Cardiol 14, 1429-1437 (1989)
12. Pandian NG, Kreis A, Brockway B: Detection of intraarterial thrombus by intravascular high frequency two-dimensional ultrasound imaging in vitro and in vivo studies. Am J Cardiol 65, 1280-1283 (1990)
13. Ellis SG, Roubin GS, King SB III, Douglas JS Jr, Weintraub WS, Thomas RG, Cox WR: Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 77, 372-379 (1988)
14. de Feyter PJ, van den Brand M, Jaarman G, van Domburg R, Serruys PW, Suryapranata H: Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty: Frequency, prediction, clinical course, management, and follow-up. Circulation 83, 927-936 (1991)
15. Haft JI, Goldstein JE, Niemiera ML: Coronary arteriographic lesion of unstable angina. Chest 92, 609-612 (1987)
16. Bresnahan DR, Davis JL, Holmes DR Jr, Smith HC: Angiographic occurrence and clinical correlates of intraluminal coronary artery thrombus: Role of unstable angina. J Am Coll Cardiol 6, 285-289 (1985)
17. Dougherty KG, Gaos CM Bush HS, Leachman DR, Ferguson JJ: Activated clotting times and activated partial thromboplastin times in patients undergoing coronary angioplasty who receive bolus doses of heparin. Cath and CV Diag 26, 260-263 (1992)
18. Bowers J, Ferguson JJ III: The use of activated clotting times to monitor heparin therapy during and after interventional procedures. Clin Cardiol 17, 357-361 (1994)
19. Ferguson JJ, Dougherty KG, Gaos CM, Bush HS, Marsh KC, Leachman DR: Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 23, 1061-1065 (1994)
20. Warner MF, Mian MS, Missri JC: Activated clotting-time variability in patients undergoing coronary angioplasty. Clin Cardiol 17, 372-374 (1994)
21. Blumenthal RS, Wolff MR, Resar JR, Coombs VJ, Brinker JA: Preprocedural anticoagulation does not reduce angioplasty heparin requirements. Am Heart J 125, 1221-1225 (1993)
22. Vaitkus PT, Herrmann HC, Laskey WK: Management and immediate outcome of patients with intracoronary thrombus during percutaneous transluminal coronary angioplasty. Am Heart J 124, 1-8 (1992)
23. Barnathan ES, Schwartz S, Taylor L, Laskey WK, Kleaveland JP, Kussmaul WG, Hirshfeld JW: Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty. Circulation 76, 125-134 (1987)
24. Lukas Laskey MA, Deutsch E, Hirshfeld JW Jr, Kussmaul WG, Barnathan E, Laskey WG: Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in patients with coronary arterial thrombus. Am J Cardiol 65, 179-182 (1990)
25. Deligonul U, Gabliani GI, Caralis DG, Kern MJ, Vandormael MG: Percutaneous transluminal coronary angioplasty in patients with intracoronary thrombus. Am J Cardiol 62, 474-476 (1988)
26. The TIMI IIIB Investigators: Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial. Circulation 89, 1545-1556 (1994)
27. Ambrose JA, Almeida OD, Sharma SK, Torre SR, Marmur JD, Israel DH, Ratner DE, Weiss MB, Hjemdahl-Monsen CE, Myler RK, Moses J, Unterecker WJ, Grunwald AM, Garrett JS, Cowley MJ, Anwar A, Sobolski J, for the TAUSA investigators: Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina: Results of the TAUSA trial. Circulation 90, 69-77 (1994)
28. Ambrose JA, Torre SR, Sharma SK, Israel DH, Monsen CE, Weiss M, Unterecker W, Grunwald A, Moses J, Marshall J, Bunnell P, Sobolski J: Adjunctive thrombolytic therapy forangioplasly in ischemic rest angina: Results of a double-blind randomized pilot study. J Am Coll Cardiol 20, 1197-1204 (1992)
29. Goudreau E, DiSciascio G, Vetrovec GW, Chami Y, Kohli R, Warner M, Sabri N, Cowley MJ: Intracoronary urokinase as an adjunct to percutaneous transluminal coronary angioplasty in patients with complex coronary narrowings or angioplasty-induced complications. Am J Cardiol 69, 57-62 (1992)
30. Schieman G, Cohen BM, Kozina J, Erickson JS, Podolin RA, Peterson KL, Ross J Jr, Buchbinder M: Intracoronary urokinase for intracoronary thrombus accumulation complicating percutaneous transluminal coronary angioplasty in acute ischemic syndromes. Circulation 82, 2052-2060 (1990)
31. Verna E, Repetto S, Boscarini M, Onofri M, Qing LG, Binaghi G: Management of complicated coronary angioplasty by intracoronary urokinase and immediate re-angioplasty. Cath CV Diagn 19, 116-122 (1990)
32. Pavlides GS, Schreiber TL, Gangadharan V, Puchrowicz S, O'Neill WW: Safety and efficacy of urokinase during elective coronary angioplasty. Am Heart J 121, 731-737 (1991)
33. Lefkovits J, Plow EF, Topol EJ: Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 332, 1553-1559 (1995)
34. The EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 330, 956-961 (1994)
35. The EPIC Investigators: Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months. Lancet 1994;343:881-886
36. Simoons M, for the European Cooperative Study Group: Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. Circulation 1994;89:596-603
37. The IMPACT Investigators: Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker integrelin in elective coronary intervention. Circulation 1995;91:2151-2157
38. Ferguson JJ III: EPILOG and CAPTURE trials halted because of positive interim results. Circulation 1996;93:637
39. van den Bos AA, Deckers JP, Heyndrickx GR, Laarman G, Suryapranata H, Zijlstra F, Close P, Rijnierse JJMM, Buller HR, Serruys PW: Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty. Circulation 88, 2058-2066 (1993)
40. Bittl JA, Strony J, Brinker JA, Ahmed WH, Meckel CR, Chaitman BR, Maraganore J, Deutsch E, Adelman B: Treatment with bivulirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. N Engl J Med 1995; 333(12):764-769
41. Gasperetti CM, Feldman MD, Burwell LR, Angello DA, Haugh KH. Owen RM, Powers ER: Influence of contrast mediaon thrombus formation during coronary angioplasty. J Am Coll Cardiol 18, 443-450 (1991)
42. Grines CL, Schreiber TL, Savas V, Jones DE, Zidar FJ, Gangadharan V, Brodsky M, Levin R, Safian R, Puchrowicz-Ochocki S, Castellani MD, O'Neill WW: A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996;27:1381-1386
43. Fischell TA, Derby G, Tse TM, Stadius ML: Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. Circulation 78, 1323-1334 (1988)
44. Golino P, Ashton JH, Buja M, Rosolowsky M, Taylor AL, McNatt J, Campbell WB, Willerson JT: Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo: Thromboxane A2 and serotonin are possible mediators. Circulation 79, 154-166 (1989)
45. Zeiher AM, Schachinger V, Weitzel SH, Wollschlager H, Just H: Intracoronary thrombus formation causes focal vasoconstriction of epicardial arteries in patients with coronary artery disease. Circulation 83, 1519-1525 (1991)
46. Lam JYT, Chesebro JH, Fuster V: Platelets, vasoconstriction, and nitroglycerin during arterial wall injury: A new antithrombotic role for an old drug. Circulation 78, 712-716 (1988)
47. Lincoff AM, Popma JJ, Ellis SG, Hacker JA, Topol EJ: Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profile. J Am Coll Cardiol 19, 926-935 (1992)
48. Christensen CW, Lassar TA, Daley LC, Rieder MA, Schmidt DH: Regional myocardial blood flow with a reperfusion catheter and an autoperfusion balloon catheter during total coronary occlusion. Am Heart J 119, 242-248 (1990)
49. Sundram P, Harvey JR, Johnson RG, Schwartz MJ, Baim DS: Benefit of the perfusion catheter for emergency coronary artery grafting after failed percutaneous transluminal coronary angioplasty. Am J Cardiol 63, 282-285 (1989)
50. Gu S, Ducas J, Wolfe K, Patton JN, Prewitt RM: Coronary thrombolysis with recombinant tissue plasminogen activator: Intracoronary vs intravenous administration. Chest 100, 201-206 (1991)
51. Hartmann JR, McKeever LS, Stamato NJ, Bufalino VJ, Marek JC, Brown AS, Goodwin MJ, Cahill JM, Enger EL: Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts by extended infusion of urokinase: Initial results and short-term clinical follow-up. J Am Coll Cardiol 18, 1517-1523 (1991)
52. Kjellgren O, Willentz JR, Kaganovsky L, Sherman W: Prolonged intracoronary infusion of streptokinase: An alternative pharmacologic approach to extensive thrombus in native coronary artery. Cath CV Diagn 33, 80-84 (1994)
53. McKay RB, Fram DB, Hirst JA, Kiernan FJ, Primiano CA, Rinaldi MJ, Azriu MA, Mitchel JF, Waters DD: Treatment of intracoronary thrombus with local urokinase infusion using a new, site-specific drug delivery system: The Dispatch TM Catheter. Cath CV Diagn 33, 181-188 (1994)
54. Tennant SN, Dixon J, Venable TC, Page HL Jr, Roach A, Kaiser AB, Frederiksen R, Tacogue L, Kaplan P, Babu NS, Anderson EE, Woolen E, Jennings HS III, Breinig J, Campbell WB: Intracoronary thrombolysis in patients with acute myocatdial infarction: Comparison of the efficacy of urokinase with streptokinase. Circulation 69, 756-760 (1984)
55. Eisenberg PR, Miletich JP, Sobel BE, Jaffe AS: Differential effects of activation of prothrombin by streptokinase compared with urokinase and tissue-type plasminogen activator (t-PA). Thromb Res 50, 707-717 (1988)
56. Muhlestein JB, Gomez MA, Karagounis LA, Anderson JL: "Rescue ReoPro": Acute utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty (abstr). Circulation 1995;92(8):I-607
57. Ferguson JJ, Dear WD, Leatherman LL, Safian RD, King SB, Douglas JS, Spears JR, and the LBA Study Group: A multi-center trial of laser balloon angioplasty for abrupt closure following PTCA(abstr). J Am Coll Cardiol 15(2), 25A (1990)
58. Brown SE, Segar DS, Weinberg BA, Bourdillon PDV, Dillon JC: Transcatheter aspiration of intracoronary thrombus after myocardial infarction. Am Heart J 120, 688-690 (1990)
59. Gianturco-Roubin Intracoronary Stent Investigator Group: Major clinical events after coronary stenting: The multicenter registry of acute and elective Gianturrco-Roubin stent placement. Circulation 1994;89:1126-1137
60. Herrmann HC, Buchbinder M, Clemen MW, Fischman D, Goldberg S, Leon MB, Schau RA, Tierstein P, Walker CM, Hirshfeld JW Jr: Emergent use of balloon-expandable coronary artery stent for failed percutaneous transluminal coronary angioplasty. Circulation 86, 812-819 (1992)
61. Carey L, Cameron J, Aroney C, Bett N, Holt G, Mahononda N, McEniery P: Experience with the Gianturco-Roubin stent for abrupt vessel closure complicating percutaneous transluminal coronary angioplasty. Aust NZ J Med 24, 31-35 (1994)
62. Dewhurst TA, Bruneau R, Titus B, Clement TJ, Auth DA, Ritchie JL: Percutaneous rotational thrombectomy reduces acute reocclusion in an animal model of acute coronary thrombosis. Cath CV Diagn 30, 120-126 (1993)